These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
854 related items for PubMed ID: 26932360
1. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study. White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM. Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360 [Abstract] [Full Text] [Related]
2. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology. Peeters E, Wentzensen N, Bergeron C, Arbyn M. Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902 [Abstract] [Full Text] [Related]
3. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A. Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534 [Abstract] [Full Text] [Related]
4. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group. Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096 [Abstract] [Full Text] [Related]
5. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y, Zhao J, Hu J, Wu XW, Zhu LR. Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267 [Abstract] [Full Text] [Related]
6. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA. Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J. Anticancer Res; 2015 Nov 25; 35(11):6291-5. PubMed ID: 26504065 [Abstract] [Full Text] [Related]
7. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Int J Med Sci; 2013 Nov 25; 10(12):1602-7. PubMed ID: 24151431 [Abstract] [Full Text] [Related]
8. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women. Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C. Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365 [Abstract] [Full Text] [Related]
9. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study. El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group. Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481 [Abstract] [Full Text] [Related]
10. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand. Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S. Asian Pac J Cancer Prev; 2014 Jan 15; 15(24):10961-6. PubMed ID: 25605209 [Abstract] [Full Text] [Related]
11. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M. Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168 [Abstract] [Full Text] [Related]
12. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. Possati-Resende JC, Fregnani JH, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C. PLoS One; 2015 Aug 01; 10(7):e0134445. PubMed ID: 26230097 [Abstract] [Full Text] [Related]
13. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F. Acta Cytol; 2012 Aug 01; 56(5):506-14. PubMed ID: 23075891 [Abstract] [Full Text] [Related]
14. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions. Vrdoljak-Mozetič D, Krašević M, Verša Ostojić D, Štemberger-Papić S, Rubeša-Mihaljević R, Bubonja-Šonje M. Cytopathology; 2015 Feb 01; 26(1):10-8. PubMed ID: 24261348 [Abstract] [Full Text] [Related]
15. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more. Siebers AG, van der Linden H, Vedder JEM, Bekkers RLM, Melchers WLG, Bulten J. Cytopathology; 2018 Jun 01; 29(3):275-280. PubMed ID: 29575519 [Abstract] [Full Text] [Related]
16. High risk HPV testing in the triage of repeat ASC-US and LSIL. Veijalainen O, Tuomisaari S, Luukkaala T, Mäenpää J. Acta Obstet Gynecol Scand; 2015 Sep 01; 94(9):931-6. PubMed ID: 26053676 [Abstract] [Full Text] [Related]
17. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study. Fujii T, Saito M, Hasegawa T, Iwata T, Kuramoto H, Kubushiro K, Ohmura M, Ochiai K, Arai H, Sakamoto M, Motoyama T, Aoki D. Int J Clin Oncol; 2015 Feb 01; 20(1):134-42. PubMed ID: 24744261 [Abstract] [Full Text] [Related]
18. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL. Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033 [Abstract] [Full Text] [Related]
19. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China. Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ, Chen W, Sun XB. Cancer Epidemiol; 2019 Apr 19; 59():123-128. PubMed ID: 30739069 [Abstract] [Full Text] [Related]
20. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ. Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]